Winston Medical Supply Co., Ltd. (6817.TWO)

TWD 94.2

(-0.21%)

EBITDA Summary of Winston Medical Supply Co., Ltd.

  • Winston Medical Supply Co., Ltd.'s latest annual EBITDA in 2023 was 228.32 Million TWD , up 28.67% from previous year.
  • Winston Medical Supply Co., Ltd.'s latest quarterly EBITDA in 2024 Q2 was 45.29 Million TWD , down -2.06% from previous quarter.
  • Winston Medical Supply Co., Ltd. reported an annual EBITDA of 177.44 Million TWD in 2022, up 13.95% from previous year.
  • Winston Medical Supply Co., Ltd. reported an annual EBITDA of 155.72 Million TWD in 2021, up 24.56% from previous year.
  • Winston Medical Supply Co., Ltd. reported a quarterly EBITDA of 46.24 Million TWD for 2024 Q1, down -24.42% from previous quarter.
  • Winston Medical Supply Co., Ltd. reported a quarterly EBITDA of 50.6 Million TWD for 2023 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of Winston Medical Supply Co., Ltd. (2023 - 2019)

Historical Annual EBITDA of Winston Medical Supply Co., Ltd. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 228.32 Million TWD 28.67%
2022 177.44 Million TWD 13.95%
2021 155.72 Million TWD 24.56%
2020 125.02 Million TWD 370.85%
2019 31.96 Million TWD 0.0%

Peer EBITDA Comparison of Winston Medical Supply Co., Ltd.

Name EBITDA EBITDA Difference
Allied Biotech Corporation 204.79 Million TWD -11.491%
GeneFerm Biotechnology Co., Ltd. 231.09 Million TWD 1.198%
Easywell Biomedicals, Inc. -85.5 Million TWD 367.044%
TTY Biopharm Company Limited 1.52 Billion TWD 85.022%
Synmosa Biopharma Corporation 1 Billion TWD 77.365%
Orient EuroPharma Co., Ltd. 582.93 Million TWD 60.832%
Center Laboratories, Inc. -175.17 Million TWD 230.345%
Tien Liang BioTech Co., Ltd. 31.04 Million TWD -635.394%
Orient Pharma Co., Ltd. 172.39 Million TWD -32.443%
InnoPharmax Inc. -62.12 Million TWD 467.555%
Johnson Chemical Pharmaceutical Works Co., Ltd. 126.67 Million TWD -80.24%
Excelsior Biopharma Inc. -29.36 Million TWD 877.435%
DV Biomed Co., Ltd. 407.64 Million TWD 43.989%
Foresee Pharmaceuticals Co., Ltd. -912.16 Million TWD 125.031%
Handa Pharmaceuticals, Inc. 802.78 Million TWD 71.558%
UniPharma Co., Ltd. -16.25 Million TWD 1504.731%
Anxo Pharmaceutical Co., Ltd. 131.31 Million TWD -73.882%
Alar Pharmaceuticals Inc. 394.52 Million TWD 42.126%
Mercury Biopharmaceutical Corporation -39.03 Million TWD 684.939%
Bioray Biotech Co., Ltd 12.13 Million TWD -1781.541%
TSH Biopharm Corporation Limited 99.35 Million TWD -129.819%